newsfilter
← Latest News
GlobeNewswire·

Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference

SHC
  • Sotera Health Company (NASDAQ: SHC) presented at the 44th Annual J.P. Morgan Healthcare Conference in Cleveland on Jan. 12, 2026.
  • Management provided an update on the business, noting a solid growth trajectory in 2025 with revenue expected to exceed $1.16 billion.
  • The projected revenue increase represents at least a 5.5% year-over-year rise, or 5.0% on a constant-currency basis.
  • The reported growth marks over two decades of consecutive year-over-year revenue increases.
  • Chairman & CEO Michael B. Petras, Jr. stated the company will share full-year 2025 results & a 2026 outlook on Feb. 24, 2026.
  • The company operates through three business segments: Sterigenics, Nordion, & Nelson Labs.
  • Preliminary financial estimates for the year ended Dec. 31, 2025, are based on incomplete closing procedures & may vary from final results.
  • The presentation webcast & materials are available on the company's Investor Relations website, with a replay archived within 48 hours.
  • Forward-looking statements carry risks including supply disruptions, geopolitical instability, foreign currency fluctuations, regulatory changes, & litigation related to Ethylene Oxide emissions.
  • Specific legal risks include ongoing litigation regarding EO releases from facilities in California, Georgia, Illinois, & New Mexico, as well as potential settlement conditions for the former Willowbrook, Illinois facility.
  • Additional risks involve operational hazards, cybersecurity incidents, supply chain disruptions, labor regulations, significant leverage, & compliance with evolving data privacy laws.